Same Indication

Nivolumab vs Semaglutide

Nivolumab vs Semaglutide: Overview

This comparison examines the pharmacological differences between Nivolumab and Semaglutide.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Semaglutide: GLP-1 receptor agonist with enhanced albumin binding for extended action.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Semaglutide — 7 days.

Chemical Properties

Type: Nivolumab — Antibody; Semaglutide — Protein.